Good day and thank you for standing by. Welcome to the OSI Systems, Inc. First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation there will be a question-and-answer session. Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your speaker today, Alan Edrick, Chief Finance Officer. Please go ahead.

Well, thank you. Hello and thank you for joining us. I am Alan Edrick, Executive Vice President and CFO of OSI Systems, and I am here today with Deepak Chopra, OSI’s President and CEO. Welcome to the OSI Systems’ fiscal 2023 first quarter conference call. We are pleased that you can join us as we review our financial and operational results. Earlier today, we issued a press release announcing our first quarter of fiscal 2023 financial results. Before we discuss these results, however, I would like to remind everyone that today’s discussion will include forward-looking statements and the company wishes to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, with respect to such forward-looking statements. All forward-looking statements made on this call are based on currently available information and the company undertakes no obligation to update any forward-looking statement based on subsequent events or new information or otherwise. During today’s call, we will refer to both GAAP and non-GAAP financial measures when describing the company’s results. For information regarding non-GAAP measures and GAAP measures of the company’s results and a quantitative reconciliation of those figures, please refer to today’s earnings release. I will begin with a discussion of our Q1 financial performance and then turn the call over to Deepak for an overview of our business performance. We will then finish with more detail regarding our financial results and a discussion of our outlook for the year. Our first quarter revenues and earnings were generally consistent with our expectations. We anticipated a softer start to the fiscal year with momentum building beginning in Q2 as supported by the timing of planned deliveries from our significant backlog. As we navigate the current economic environment, including supply chain delays and increased costs, disruptive geopolitical events, inflation and rising interest rates along with the ongoing effects of COVID-19, we continue to prioritize delivering on commitments to our customers and business partners and positioning the company for long-term success. Now we will go through a high level summary of our financial results. First, we reported Q1 revenues of $268 million, a 4% year-over-year decrease. These results included an approximately $4 million adverse FX impact. Second, we reported adjusted earnings per share of $0.87, down from $1.16 in Q1 of the prior year, as a result of the reduced revenues just noted, a less favorable mix of sales and additional interest expense under the credit facility, which was increased in December 2021 with the primary objective of retiring the convertible notes. Third, Q1 bookings were solid, with a book-to-bill ratio of approximately 1.2, leading to a record quarter end backlog of nearly $1.3 billion. And finally, operating cash flow for the first quarter was $17 million, representing a $28 million improvement over Q1 of the prior year. Capital expenditures of approximately $3 million were consistent with the same prior year quarter. We were again active in our stock repurchase program, spending approximately $17 million in the quarter, and then further last month, our Board increased to 2 million shares the number of shares authorized in our stock buyback program. Before diving more deeply into our financial results and discussing the fiscal 2023 outlook, I will turn the call over to Deepak.

Thank you, Alan, and good morning to all of you. Our fiscal 2023 first quarter’s performance was generally to our expectations. As Alan mentioned, we expected the revenue growth in fiscal 2023 to be more skewed towards the second quarter, third quarter and fourth quarter. We had very good bookings quarter, achieving a book-to-bill ratio of 1.2. Despite our start to the fiscal year, with a significant backlog and near-term visibility on certain attractive opportunities, we expect the 2023 fiscal year to be in line with our initial revenue and adjusted earnings guidance, implying strong growth for the next nine months. Our operating cash flow in Q1 exceeded operating cash flow in the same quarter last year and we anticipate even greater operating cash flow over the balance of the year. I will now talk about each division’s performance in the quarter, starting with the Security division where Q1 revenues were 3% lower year-over-year and bookings were approximately $204 million for a book-to-bill ratio of 1.4 for the quarter. The lower operating margin in the Security division for the quarter was mainly due to the product mix and lower revenue of the division. We expect Security division operating margins to improve significantly as we progress through the rest of the year. Overall demand for checkpoint Security products and related services continued to improve as airport and related activities have ramped up. We saw higher demand for our supplies and accessories also, which include consumable items that are a recurring revenue source. Rapiscan’s inspection systems will be used at the FIFA World Cup 2022 to be held in Qatar. We are finalizing our preparation for the event, which starts in late November. Our ORION 920CX baggage and parcel inspection systems, Large Tunnel 922CX models and Metor 6S walk-through metal detectors will be among the equipment utilized to screen thousands of people and bags daily during this prestigious soccer event. We continue during the quarter to stay active in pursuing and securing port and border security customer opportunities both in U.S. and international. We had multiple wins and announced a couple of them. We received an order for $22 million to provide comprehensive service, maintenance and spare parts support for various Rapiscan cargo and vehicle inspection CVI systems deployed internationally. The most significant activity at the border for us relates to the large orders we received from the U.S. Customs and Border Protection that are expected to be delivered primarily over the next two to three years. Our cargo and vehicle inspection products are used extensively at borders to prevent contraband and illicit materials and drugs, such as phenethyl and methamphetamine, from crossing into the U.S. We continued to deliver these inspection products to CBP in Q1 with a modest amount of revenue, anticipating significant revenues from this CBP program over the balance of this fiscal year and in fiscal 2024. However, the timing can shift a bit due to customer needs and assessments. We also continue to invest in technology and solutions that enhance our security offering and can drive recurring revenues. During the quarter, we completed the acquisition of a small strategic acquisition called Quadriga, a UK-based provider of training core software for checkpoint security operators. We expect to further develop this technology and integrate it with our existing CertScan software platform and training modules to broaden our standalone subscription offering for security customers. CertScan is a common integration platform designed specifically to work in multi-system, multi-site, security inspection programs and help customs and security operators perform at the highest levels. CertScan is deployed at major ports and checkpoints worldwide and is getting much more publicity and acceptance. Our turnkey service operations in Puerto Rico, Albania and Guatemala continue to do well, as our customers rely on these programs for security and to enforce regulatory trade and tariff requirements. The revenues from the services vary from quarter to quarter in relation to the specific volume of port activity. During the quarter, we added a new multiyear turnkey services customer during the first fiscal quarter. Although small in size, this is very significant as it’s a first in the airport aviation sector. The services are expected to include daily screening of the airport staff and crew and screening vehicles and occupants at the airport’s perimeter access control points. Security’s backlog is strong and increasing activity across many of our end markets provides a lot of confidence for the remainder of 2023. Moving to the Optoelectronic and Manufacturing division. Opto delivered strong results in the first fiscal quarter with $94 million in revenue, including intercompany revenue, which is an all-time quarterly record with strong growth in the division’s operating profit. Opto’s momentum is expected to continue as our backlog at the end of Q1 2023 was 22% higher than the backlog at the end of Q1 2022. Opto has been gaining new customers and becoming a preferred supplier for many OEM customers. As an example of high customer satisfaction during the quarter, our Flex operation was awarded ZOLL’s Heart Safe Hero award for being a valued critical supplier to ZOLL’s heart defibrillation product lines, which is a great honor. In addition to the healthcare, Opto’s OEM customer base is diversified in multiple markets, including defense, space, consumer hi-tech, industrial and automotive. Given the anticipated higher demand in Opto, we have expanded our operations for manufacturing in Canada, India and in Batam, Indonesia. Turning now to the Healthcare division where Q1 was a challenging quarter, with sales down 14% year-over-year. Q1 was a tough comp as last year’s quarter still had heightened sales given the spike in cases with the COVID Delta variant around that time. During the quarter, we have several orders from various U.S. hospitals and we announced one of the larger ones, a $4 million order to provide patient monitoring solutions and related accessories to a U.S. based hospital in which we expect to provide Xhibit Central Stations, Aurel Telemetry, Expression Patient Monitors, Qube Patient Monitors and SafeNSound patient management software. We have been increasingly successful in adding software modules such as SafeNSound to the bundled patient monitoring products, which lifts the recurring revenue portion of our overall sales and differentiates our products from our competitors. We continue to invest in R&D in Healthcare to bolster our core offerings. Our customers are increasingly looking for solutions with enhanced connectivity and remote monitoring capabilities, which are the focus of our R&D efforts. With significant backlog in Security and Opto, we feel good about our prospects in these divisions for the balance of 2023, and we also expect stronger performance from Healthcare as we look forward to the rest of the fiscal 2023. With that, I will turn the call back over to Alan Edrick to talk in more detail about our financial performance before opening the call for questions. Thank you.

Thank you, Deepak. Now let’s review the financial results for our first quarter in greater detail. Our first quarter revenues were down 4% compared with that of the prior year Q1 or approximately 2% on a constant currency basis given the strength of the dollar. Fiscal first quarter Security division revenues were down 3%, largely due to the unfavorable FX impact. The Security division book-to-bill as Deepak mentioned was approximately 1.4, positioning the division well going forward and we anticipate significant sales growth commencing this quarter. Opto sales increased 2% year-over-year on the growth of intercompany sales to support anticipated upcoming security sales, while Opto third-party sales were consistent with third-party sales in the prior year quarter. Opto bookings were again solid, leading to a record Opto backlog, but supply chain constraints have led to delays in production and shipments of certain orders. The Healthcare division reported a 14% reduction in year-over-year revenues in part due to a tougher year-over-year comp, given the prior year demand during the COVID Delta variant surge. The Q1 gross margin was 32.6%, about 2.9% below that of the prior year. This change was primarily driven by the lower sales in the Healthcare division, which carries the highest gross margin of our three divisions, higher Opto sales as a percentage of total sales, as this division tends to carry the lowest gross margin of the three divisions, and a less favorable mix in the Security division sales with increases in certain component and freight costs adversely impacting each division’s gross margin. Our gross margin, in general, will fluctuate from period to period based on revenue mix and volume, inflation, impacts to the supply chain, among other factors. Moving to operating expenses, we continue to work diligently across each of our divisions to improve efficiencies and prudently manage our SG&A cost structure. Our Q1 results again demonstrated the success of these efforts. Q1 SG&A expenses were $53.4 million or 19.9% of sales, compared to $57.3 million or 20.5% of sales in the prior year Q1. While foreign exchange was a headwind to the top line revenues, it did have a beneficial impact on our operating expenses. Research and development expenses in Q1 of fiscal 2023 were $14.5 million, relatively consistent with that of the prior year. We continue to dedicate considerable resources to R&D, particularly in Security and Healthcare, as we remain focused on innovative product development, which we view as vital to the long-term success of our businesses. In Q1 of fiscal 2023, we recorded $1.2 million of restructuring and other charges, compared to $2.5 million of such charges in Q1 of the prior fiscal year. Moving to interest and taxes. Net interest and other expense in Q1 of 2023 increased to $3.4 million from $2 million in the same prior year period, primarily due to rising interest rates and the maturity of our 1.25% convertible notes on September 1st, which were at a lower rate than our current borrowings. We executed an interest rate swap during Q1 to fix a portion of our floating rate debt. On the tax side, our reported effective tax rate under GAAP was 24.4% in Q1 of fiscal 2023, compared to 15.9% in Q1 of fiscal 2022. In Q1 of fiscal 2023, we recognized a discrete tax benefit of $0.1 million, as compared to a discrete tax benefit of $2.1 million in Q1 last year. Excluding the impact of discrete tax items, our normalized effective tax rate in Q1 of 2023 was 25.1%, compared to an effective normalized rate of 25.4% in Q1 of fiscal 2022. I will now turn to a discussion of our non-GAAP adjusted operating margin. Overall, our adjusted operating margin in Q1 of fiscal 2023 decreased to 8.7% from 10.9% in the same prior year period. This was primarily driven by the reduction in revenues and gross margin previously described. We were pleased with the increase in the adjusted operating margin in our Opto division, which expanded 12.7% in the first quarter of fiscal 2023 from 11.4% in the prior fiscal year first quarter due to a more favorable product mix and implementation of certain efficiency improvement initiatives. The adjusted operating margin in the Security division decreased to 12.8% in Q1 from 16.2% in the prior year first quarter on lower revenue with reduced gross margin on a less favorable product mix. We expect nice sequential improvement in this division in Q2 on stronger revenues and a more favorable revenue mix. With lower revenues and a less favorable revenue mix, the adjusted operating margin of our Healthcare division decreased to 4.9% from 12.1% in the prior year quarter. We are forecasting this division to show significant improvement over Q1 as early as this quarter. Moving to cash flow, cash flow provided by operations was $17 million in Q1 of fiscal 2023 compared to cash used in operations of $11 million in the same prior year quarter. The increase was driven by working capital improvements. CapEx in the fiscal first quarter was $3.2 million, while depreciation and amortization in Q1 was $9.5 million. We continue to be active in our stock buyback program in Q1 of fiscal 2023, during which we spent $17.3 million to repurchase about 208,000 shares. Our Board increased the buyback authorization in September, and as of quarter end, approximately 1.9 million shares were available to repurchase under the program. Our balance sheet is solid, with net leverage of 1.6 and significant capacity for acquisitions and additional stock buybacks. We retired the convertible notes in September utilizing a combination of our revolver and term loan, which we had put in place in December 2021, primarily for this purpose, leaving plenty of liquidity. Aside from about $7 million of annual required principal payments under the term loan, the bulk of our debt matures in fiscal 2027. And finally, turning to guidance, we are reiterating our previous revenues and non-GAAP adjusted earnings per share guidance. This implies revenue growth in the range of 7% to 11% and adjusted EPS growth of 17% to 22% over the remaining nine months of fiscal 2023. The non-GAAP diluted EPS range excludes potential impairment restructuring and other charges, amortization of acquired intangible assets and non-cash interest expense, and their associated tax effects, as well as discrete tax and other non-recurring items. We currently believe this revenue and non-GAAP earnings guidance reflects reasonable estimates. The actual impact on the company’s financial results of the COVID pandemic, disruptions and increased costs in the supply chain and rising inflation and interest rates is difficult to predict and could vary significantly from the anticipated impact currently reflected in our estimates and guidance. Actual revenues and non-GAAP earnings per diluted share could also vary from the anticipated ranges due to other risks and uncertainties discussed in our SEC filings. We continue to remain focused on the growth of our businesses and continued proactive management of our cost structure. We believe our efforts in these areas will enable OSI to continue providing innovative products and solutions. We look forward to continuing to navigate through the current dynamic and challenging environment, while gaining traction in key strategic growth areas and positioning the company to capitalize on improving end markets such as aviation. We would like to take this opportunity to thank the global OSI Systems team for its continued dedication in supporting our customers and our partners. And at this time, we would like to open the call to questions.

Thank you. Please wait. And our first question comes from Brian Ruttenbur from Imperial Capital. Your line is now open.

Great. Thank you very much. Great quarter and let me jump right into questions.

Thanks, Brian.

So can you give us an update on the status of the TSA certification where you are on the CT based inspection equipment?

Yes, Brian. Hi. This is Deepak here. As we have mentioned before on the checked baggage side, the present certification that we have is 5.8, which applies to cargo and we have been very successful in that side. There is no specific qualification for the ongoing replacement cycle, which according to TSA is still a couple of years away and they are still finalizing with the European Union what the final procedure is going to be. So, at this stage, we have 5.8, same as other people and we are very successful in whatever is happening, especially in the cargo space.

Okay. Is there any update on the upgrade cycle that’s supposed to be happening, I guess, for the last five years, we have been talking about this, but in terms of the U.S. TSA with checked baggage?

Well, the only thing we know is that it is pushed out, it’s 2024, 2025, but we hear it’s not in our hands. It’s in TSA’s hands and they basically have to make their decision, and COVID has pushed everything to the right. But on the European side, there’s much more activity and we are very well qualified to win those orders.

Great. Moving onto the Opto side real quick, it continues to perform extremely well. What is driving that? Is there anything specific, such as a sector or product, that is contributing to this growth?

Well, maybe Alan can add on to it, but in my view, looking at it, all the sectors have done very well. The automotive sector has been very, very successful. Medical has been very good and it continues to show very strong growth. That’s one of the things that Alan mentioned also. The flex circuit, which is a division in the OSI Electronics has done very well and we won some great kudos from our customers. But in aerospace, in defense, in high-tech consumer electronics, industrial, name the sector, good news is that’s one of the things we are very proud about. It’s a very diversified product portfolio. And we personally think one of the things that I have said before, one of the things that has also helped us very much, is there’s a lot of desire by the OEM customers to move away from China and with our presence in Indonesia, our presence in Malaysia, our presence in India, it’s been a good blessing for us and that’s one of the reasons I said in my speech that we have expanded our facilities there. That has been a big positive. Alan?

Yeah. I think what Deepak was describing is exactly right. Our diversified model, our diversified customer base in medical, defense, aerospace, technology, industrial, automotive, amongst others has really played us well. And I would really say hats off to a lot of our sales and business development teams who are going out there and getting new business from existing customers, as well as bringing in brand new customers. So we have really seen tremendous strength in the division and we are certainly hopeful we are going to see that continue for the foreseeable future.

Great. And then just my final question is on the Healthcare division. It was weak kind of year-over-year from first quarter last year. When do you expect to see that recovery and was there a specific reason? It was weak year-over-year in this first quarter? Was there a specific shipment or a product line that didn’t go out?

Well, first of all, historically, the first quarter is relatively weak, and we anticipated that this year. Last year, COVID was still affecting demand for patient monitoring with quick turnaround, but that demand has slowed. This has resulted in a decrease, which we’re not pleased about. However, we are optimistic about the second, third, and fourth quarters as we expect them to be stronger with increased activity. One factor contributing to this is our significant investment in SafeNSound, our software platform, which has been well received and differentiates us from competitors. We view this as a growth opportunity with higher margins. Alan, would you like to add anything?

Yeah. I think that Deepak summarized it well. But, Brian, we do expect to bounce back with a stronger sequential quarter for sure here in Q2 and pick up some further strength in the second half of the year. So we do believe the performance in the Healthcare division will look much better the rest of the year compared to Q1.

Great. Thank you very much.

And thank you and one moment for our next question. And our next question comes from Larry Solow from CJS Securities. Your line is now open.

Good morning, everyone. I have a couple of follow-up questions. Deepak, you mentioned the significant orders with Customs and Border Protection, specifically the $200 million deal. Have you begun delivering on that yet? Additionally, in the last quarter, you noted some delays in deliveries. Is there any update on that situation? It's been about a year, and I believe there is still a considerable portion of the IDIQ left. What is your outlook on potential additional orders?

Larry, this is Alan. I will take the first part of the question and Deepak can follow on. So, yeah, we began delivering some of that CBP orders from the IDIQ in Q4 of last year, which continued into Q1 of this year. Pretty modest revenues, I think, as Deepak mentioned in his opening remarks this quarter. That being said, we expect to see a significant acceleration of the revenues beginning now. So we will see much bigger revenues in Q2 and Q3 and Q4 continuing on into 2024 and maybe part of 2025. So that’s kind of what our current outlook is and then we would anticipate there could be follow-on orders. Deepak, if you want to add?

Yes, this is Deepak. Alan articulated it well. The ramp-up will occur more rapidly beginning in Q2, Q3, and Q4 of this year compared to the past, and most of the delays are due to external factors, particularly the unpreparedness of civil work in certain areas. This situation is expected to carry on into 2024 and beyond. We remain confident that, with these developments, we are well positioned to secure additional bookings from the IDIQ as more products are delivered. We view this as a long-term strategy. While some circumstances are beyond our control, CBP is a focused customer with specific requirements at the border, and we are strategically aligned to meet those needs, including through our essential CertScan software.

Is CBP the only agency involved for the U.S. southern and northern borders, or are there other agencies as well? I assume there are significant international opportunities since vehicle inspection worldwide is currently minimal. There are estimates that suggest there is a desire to eventually target a large majority of commercial vehicles, if I’m not mistaken.

Well, you put it very well. CBP is the main customer in that. Yes, there is international traction and that’s why we are very excited about the CertScan software implementation also. But, in addition, one of the other comments we want to make is, there are other agencies, which is not to do with border security.

Right.

There are other agencies like State Department, the Department of Defense and stuff, also very big customers for us and we continue to get a lot of success with other divisions of the U.S. Government and international governments.

Got it. Okay. Great. I just want to quickly follow up on Brian’s question regarding the Opto segment, where you mentioned that backlog increased by 22% year-over-year. That's a significant figure. Should I assume that some of that is due to pricing, or is it primarily volume? Were there any tuck-in acquisitions contributing to this, and what drove that growth? It seems like a large number; are there any larger, longer lead time orders that might be skewing this, or is it primarily pure growth?

Larry, this is Alan. Good question. And it is all organic as we haven’t done any acquisitions during that period of time in the Opto division. What we are seeing from some of the customers with some of the challenges and supply chain and longer lead times is at times they are giving us a longer order. If somebody used to give us a three-month order, they might give us a six-month order. If somebody gave us a six-month order in the past, perhaps it might give us a nine-month order. So we are getting some larger orders as a result of that to give greater visibility going forward. A little bit of price with passing on certain purchase price variances and stuff with inflation, and certainly, growth in unit volume as well, so really a combination of all of those factors.

Larry, just to add on…

Got you. Yeah.

It's Deepak here. I want to emphasize that there is a strong focus on moving away from China. If you have built strong relationships with your customers, the capability to support them, and an efficient supply chain along with our facilities, which we have expanded in Batam, Indonesia, Malaysia, and India, this has significantly helped us capture more business from our regular customers. These customers are now more inclined to see growth and prefer working with a select group of vendors, and we are well-positioned in various locations and have proven to be a reliable supplier.

All right. Great. I appreciate that color. Awesome. Just last question just on the cash flow, Alan, I know Q1, obviously, was a little bit certainly into the back-end loaded year, but the operating cash flow did exceed net income in the quarter even on adjusted basis. Do you expect that to continue on a full year basis? I don’t think you guys are, typically it’s a free cash flow, but do you expect operating cash flow and free cash flow to, obviously, improve over last year? But do you expect it to sort of come close to net income as it has in the past?

Yeah. Larry, while we did not provide cash flow guidance per se, we really think there is opportunity for strong free cash flow in fiscal 2023.

Okay.

That being said, we do expect inventory to remain at an elevated level this year. But in terms of the conversion, I do think we can have very strong conversion certainly north of where we were last year and approaching where we used to be in the past. And all three of our businesses are finely tuned to the key levers that drive the strong operating cash flow and free cash flow. So, yeah, some great opportunity there.

Got it. Great. Thanks. Thanks again.

And thank you and one moment for our next question. And our next question comes from Christopher Glynn from Oppenheimer. Your line is now open.

Thank you. Good morning and good afternoon, depending on your location. I have a question about Optoelectronics. Could you provide some details on the past due backlog? Additionally, as you manage to improve this situation, will there be a noticeable increase in run rate connected to the migration from China? It appears that this business is somewhat constrained, and despite the positive numbers, the context you provided suggests it may still be in a different situation.

Yes, Chris, that's a great question. This is Alan. I wouldn't exactly label it as a past due backlog, since we are collaborating effectively with all our customers. However, there is likely some opportunity, probably less than $10 million in extra revenue we could have achieved if it weren't for specific component shortages. You might have 98% of the necessary parts, but without the last 2%, you can't ship a complete product. So, it's not a significant backlog that would lead to a substantial increase in revenue. We do, however, anticipate ongoing strength in the business each quarter for the remainder of the fiscal year.

This is Deepak. I mean I think Alan has put it well. I will also emphasize to it that we are very much focused on what we call value-added. So if you are working with the customer to supply $5 of parts, the focus now with a broad technology and our global presence, we are trying to work out can we add more value to that, which is a very, very good strategy for the Opto group, because that gets us higher on the food chain on the customer’s list, and as the customer looks at it, we basically continue to work with them to get more value-added that we can supply, which we think long term will continue to grow.

Great. And one on Security,. You have had backlog there and a big chunk from the CBP. And in some cases, backlog businesses have a little bit more challenged with price cost. It certainly sounds like you have flushed out the worst of price cost mismatch in backlog in the current quarter. But I just want to revisit first affirm from that point or clarify and then with the big IDIQ win, how do you preserve the economics of those wins from when you bid and is that even possible?

Good question. You are absolutely right, on longer term contracts, price is fixed, so you can’t change it. But we haven’t seen, though, that there has been some push outs and scrap, because of component shortages and site not ready. But I would say on a bigger scale up till now we have not seen too much erosion of our margin on the products. And the same way, think about it that all indications are that there is some easing in the supply chain, both in freight and in component costs and stuff. So as we push that product out with a longer time frame we have, we expect that things will stabilize.

Great. Thank you.

And thank you and one moment for our next question. And our next question comes from Jeff Martin from ROTH Capital. Your line is now open.

Thanks. Good morning, Alan and Deepak. Hope you are doing well. Deepak, I wanted to see if you could give us a little more detail around the traction that CertScan may be getting, is it still too early to be talking too much about that? Also curious about how long the sales cycle is there and when we might expect to see a little more accelerated ramp for it?

Again, good question.

And as you say, secondarily, how that ties into the Quadriga acquisition that you have mentioned this morning?

Thank you for the question, Jeff. Progress with CBP has been slow this quarter, but we anticipate stronger performance in the second, third, and fourth quarters, continuing into 2024. As our installed base grows, it will also include the CertScan software. Additionally, we have received certification for ATO, which is a significant advantage for installing the software at various customer locations. While progress is gradual, Quadriga enhances our offerings by combining training and CertScan, allowing us to provide more applications and support for additional customer functions. Our focus remains on making this software a recurring revenue licensing model not only in the U.S. but globally. It's an educational process as we work with our customers to meet their needs, but the signs point to gaining traction, particularly with CBP.

Okay. Great. And then you would mentioned that first new multiyear turnkey customer in airport aviation. I am curious in a little bit of background how that opportunity evolved and eventually came to light, and then, what you are thinking in terms of, is that a major strategic initiative for Rapiscan going forward?

I will address it in reverse order. First, if you look at our track record from five or ten years ago, we've essentially ventured into a new line of business. Our turnkey solutions related to ports and borders have been very well received and successful. We are actively exploring additional opportunities. Aviation is one such area that has garnered a lot of attention recently. As you've likely seen, there are challenges in conducting inspections quickly enough, and the availability of labor is limited. Therefore, automation in this sector makes perfect sense. We've shown our clients what can be achieved in port and border security, and we've had a successful entry into aviation internationally. Although this segment is still small, it represents the beginning of a new market opportunity for us in aviation. We are putting in significant effort into this area. While it's not yet a game-changer, it's strategically valuable, and as we build on this success and present our solutions to more customers, we believe it could develop into a new market.

Great. And last question with the hurricane going through Puerto Rico and causing significant disruption. I was just curious if you saw any disruption with your turnkey operations there.

Jeff, this is Alan. No significant disruption, obviously for a few days while it was occurring, but our general volumes in Puerto Rico tend to be about the same, some delays and some paperwork and the like down there, but overall, no significant change in Puerto Rico.

And just to add on to it, fortunately, no damage to our equipment and our employees are all safe. And during all this time, we work diligently and we continued, as Alan mentioned, we are continuing to work.

Excellent. Thanks for your time, guys.

Thank you.

And thank you. Please wait. One moment for our next question. And our next question comes from Josh Nichols from B. Riley. Your line is now open.

Yeah. Thanks for taking my question. One, I just want to ask a little bit about the small acquisition that you did. I know that that’s going to be integrated with CertScan. Could you elaborate a little bit on that and progress that the company has made growing its more SaaS revenue base and the opportunity on that front as we look out a little bit further?

Well, good question. It’s a very small acquisition. They do training. They are based in the UK. They do training for people in the inspection space at checkpoints. We had been using them as a vendor for some time and thought it was strategically good that now we know about it to combine it so that we can broaden our CertScan platform for opening more applications to our broader customer base. And, yes, it’s all heading towards a SaaS model between CertScan and Quadriga and we feel that we will continue. But, again, I want to emphasize, and again, before the other person asks the question, we definitely believe long-term this will continue to grow. It’s a slow part. It’s a new area we are entering into. We are working with our customers. And according to the SaaS model, we look at it as a licensing plus good margin. And we are also very much focused on to it that it’s agnostic to which equipment it’s hooked on to whether it’s Rapiscan equipment or a competitor’s equipment, whether it’s X-ray machines, whether it’s television cameras or whatever. So we continue to broaden our application need for this software model.

Thanks. And then just curious, so the new turnkey that you announced, small in size, but a first in the airport aviation sector, is this like a land and expand opportunity? Could this become more meaningful? I am just curious about the growth opportunities here or if there’s more opportunities in the aviation sector where previously you haven’t really done so much on the turnkey side?

Yes, we have a multiyear contract that is starting small to assess its viability. As it grows, even with our current customer, it has the potential for significant expansion as more applications are integrated. Additionally, we believe this model, which we have successfully implemented in places from Puerto Rico to Mexico to Albania, is a solid foundation for expanding into the aviation sector. We expect to see continued success as we showcase the effectiveness of this turnkey model.

Thanks. And then last question for me, just with shares kind of trading pretty depressed level 7 times to 8 times EBITDA, despite you have a record backlog and I think the outlook for this year is that growth is going to accelerate materially relative to last year. What’s your thoughts on the buyback? You have obviously been buying back pretty aggressively, but the cash over $50 million, are you comfortable allocating a very large percentage of your free cash flow to share buybacks if the stock does remain at these levels or what’s your thoughts on the capital allocation strategy there?

Well, we don’t talk about what these things are specifically in the future. But you said it very well, we are very much aggressive in it, we feel we are undervalued and we continue to look at when we are able to buy. And the Board has been very, very supportive of it with the increasing of the stock purchase plan, and we have been very active into it and we will continue to be active.

And thank you. And I am showing no further questions at this time.

Thank you everyone for joining this morning while the market is still open. I appreciate your time and want to express my gratitude to all those present. I also want to highlight my appreciation for our employees, their families, and our customers for their continued support and collaboration. We look forward to our next conference call. Thank you once again.

This concludes today’s conference call. Thank you for participating. You may now disconnect.